Strategies to screen for adrenal suppression in children with asthma: There is no consensus among UK centres

Thorax

Volumn 63, Issue 9, 2008, Pages 841-842

  Brodlie, M ^a,b   McKean, M C ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; FLUTICASONE PROPIONATE; PREDNISOLONE; TETRACOSACTIDE;

ADRENAL SUPPRESSION; ASTHMA; CLINICAL PRACTICE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SCREENING; HUMAN; HYDROCORTISONE URINE LEVEL; INSULIN HYPOGLYCEMIA; LETTER; LOW DRUG DOSE; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT; UNITED KINGDOM;

EID: 51249102154     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2008.100222     Document Type: Letter

References (6)

1. Brodlie M, McMurray A, Crofton PM, et al. Strategies to screen for adrenal suppression in children with asthma should take account of compliance with inhaled corticosteroids. Eur J Pediatr 2007;166:493-4.
2. The British Guidelines on Asthma Management. 1995 Review and Position Statement. Thorax 1997;52(Suppl 1):S1-21.
3. Todd GRG, Acerini CL, Ross-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002;87:457-61.
4. British Guideline on The Management of Asthma. Edinburgh: Scottish Intercollegiate Guideline Network, 2005.
5. Crowley S. Inhaled glucocorticoids and adrenal function: an update. Paediatr Respir Rev 2003;4:153-61.
6. Shyam R, Ullman D, Spencer D. Limited repeatability of the low dose Synacthen test in children with asthma maintained on inhaled corticosteroids. Arch Dis Child 2007;92(Suppl):A1.